Showing results (491-500 of 638) with videos related to
Sort By:
Pageof 64
ESMO Open|February 26, 2022
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatmentP Conte, P A Ascierto, G Patelli, et al.Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|May 27, 2021
Patterns and Predictors of Different Youth Responses to Attachment-Based Parent InterventionDave S Pasalich, Stephanie G Craig, Natalie Goulter, et al.Minerva Chirurgica|April 10, 2002
[Thoracoscopic esophagectomy for esophageal cancer. Personal experience]M Moretti, T De Giacomo, F Francioni, et al.The Annals of Thoracic Surgery|November 28, 2001
Pneumoperitoneum for the management of pleural air space problems associated with major pulmonary resectionsT De Giacomo, E A Rendina, F Venuta, et al.Journal of Biological Regulators and Homeostatic Agents|November 5, 2011
Biodegradable microcarriers as cell delivery vehicle for in vivo transplantation and magnetic resonance monitoringA B Lovati, E Vianello, G Talò, et al.Plos One|April 12, 2014
Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent mannerRoberta M Moretti, Marina Montagnani Marelli, Deanne M Taylor, et al.Personality Disorders|January 13, 2015
Assessing psychopathy among justice involved adolescents with the PCL:YV: an item response theory examination across genderSiny Tsang, Karen M Schmidt, Gina M Vincent, et al.American Journal of Respiratory and Critical Care Medicine|May 12, 2000
Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airwaysF L Ricciardolo, M Steinhoff, S Amadesi, et al.American Journal of Hematology|June 8, 2001
A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseasesD Gemmati, M L Serino, A Ongaro, et al.Haematologica|September 1, 1992
Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemiaG Pozzato, F Franzin, M Moretti, et al.Pageof 64